• ESMO Conference Updates and More

    The European Society of Medical Oncology (ESMO) conference wrapped up this week with many exciting announcements and developments. New studies from Lilly, AstraZeneca, Merck and others showed promise treating lung cancer, thyroid cancer, prostate cancer and more. Hospitals and medical groups are pushing back at the Trump administration’s focus on publishing payer-negotiated pricing. Read on ...

    Read More